Technology | July 12, 2010

New Beverage Improves Taste of Iodinated Contrast

July 12, 2010 – A new beverage has been released that masks the taste of oral iodinated contrast used in abdominal study CT scans. Breeza, by Beekley Corp., was developed in response to industry requests for a beverage to deliver oral iodinated contrast that patients would find more palatable, enabling them to drink the entire volume within the allotted time.

“Breeza has provided a contrast delivery product that almost every patient has tolerated well and not gagged getting down. This provides for a much more complete study and our patients appreciate having something that tastes good,” said CT scan technologist Joseph Piadade of Halifax Regional Hospital in South Boston, Va. “Patients are able to drink according to our instructions and the colon is well contrasted during the scan. We have noticed a marked decrease in intolerance and patients have no problem drinking the required amount for the study being performed.”

Breeza is sugar-free and tropical-fruit-flavored, and is sold premixed and packaged in 16 oz under-filled bottles, to allow for addition of the oral iodinated contrast. Using Breeza is also meant to save time, since facilities will not have to mix powdered drinks, coax patients to drink, employ nasogastric tubes or need to rescan.

For more information: www.beekley.com

Related Content

Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
AI Promising in Predicting Chronic Conditions From CT Scans
News | Artificial Intelligence | November 27, 2018
Zebra Medical Vision and Clalit Health Services announced the completion of two research projects that allow early...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Guerbet Showcases Ongoing Collaboration With IBM Watson at RSNA 2018
News | Clinical Decision Support | November 21, 2018
Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM Watson Health in...